Skip to main content
MNKD
NASDAQ Life Sciences

FDA Approves MannKind's Afrezza for Pediatric Diabetes, Significantly Expanding Market

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$3.809
Mkt Cap
$1.177B
52W Low
$2.23
52W High
$6.51
52W Position info
71% above low
Off High info
41% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

MNKD sits 71% above its 52-week low of $2.23.

Summary

MannKind secured FDA approval for its Afrezza insulin inhalation powder for children and adolescents aged 6 and older with Type 1 and Type 2 diabetes. This significantly expands the addressable market for Afrezza, potentially driving substantial revenue growth. The approval follows yesterday's news that the FDA released MannKind from a major postmarketing trial for Afrezza, building positive momentum for the drug. This regulatory win is crucial, especially after the company reported a net loss of $16.6 million in Q1 2026.

At the time of this announcement, MNKD was trading at $3.81 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $2.23 to $6.51. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

MNKD - Latest Insights

MNKD
Nov 05, 2026, 4:07 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.79
Real-time Price: $3.88 info
Change: +$0.085 (+2%) info
Market Cap: $1.246B info
MNKD
Nov 05, 2026, 4:01 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $3.76
Real-time Price: $3.88 info
Change: +$0.115 (+3%) info
Market Cap: $1.246B info
MNKD
Sep 09, 2026, 6:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.28
Real-time Price: $3.88 info
Change: -$0.405 (-9%) info
Market Cap: $1.246B info
MNKD
Aug 10, 2026, 7:37 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $4.12
Real-time Price: $3.88 info
Change: -$0.245 (-6%) info
Market Cap: $1.246B info
MNKD
Jul 29, 2026, 6:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $4.03
Real-time Price: $3.88 info
Change: -$0.155 (-4%) info
Market Cap: $1.246B info